Omid Hamid MD
@OmidHamidMD
Followers
5K
Following
3K
Media
785
Statuses
4K
Chief of Research and Immunotherapy • ImmunoOncology • Phase I Clinical Trials • Melanoma • Cutaneous Oncology
Los Angeles, CA
Joined November 2013
Fortunate to be recognized as Researcher of the Month by Medical Oncology Association of Southern California, Inc. ! Thank you @angelesclinic Cedars-Sinai for the opportunity https://t.co/KraTboFMMm
#oncology #thankyou #opportunity #clinicalresearch #cli… https://t.co/tDIgYOLemp
9
5
87
Our greatest partners in Medical Oncology are the collaborations with Dermato-Oncology and Surgical Oncology 23RD EADO CONGRESS April 14th–16th, 2027 HOFBURG, VIENNA https://t.co/qazeuNtY6o
#melanoma #cSCC #Skincancer #BCC #immunotherapy
1
0
2
Celebrating and Honoring those who serve @angelesclinic and throughout. #humbled @USArmy @USNavy @USMarineCorps @usairforce @USNationalGuard @CedarsSinai @CedarsSinaiMed
0
0
6
This is the algorithm for reference during our discussion with @OmidHamidMD on Melanoma! #OncTwitter #MedTwitter @OncUpdates
Treatment Algorithm series: the current Rx landscape of Melanoma with @OmidHamidMD ✅ NeoAdj and Adj Rx ✅ Role of ctDNA ✅ Rx in metastatic settings Full discussion: - https://t.co/cMev8RQIyx - Also on the “Oncology Brothers” podcast #MedTwitter #OncTwitter @OncUpdates
1
33
111
@OncBrothers @OmidHamidMD @OncUpdates @angelesclinic @BijoyTelivala @dr_yakupergun @TarekHaykal1 @DrYukselUrun @MelanomaReAlli @HemOncFellows @DrSapnaPatel @DrBetofMDPhD @Melanoma_doctor Deeply impressed, I wish the team continued breakthroughs and a bright future.
0
1
5
@OmidHamidMD Thank you for taking the time @OmidHamidMD for touching on the current treatment landscape! So much to cover in such a short time!! Will share this discussion in coming weeks 🙏🏽🙏🏽
0
1
3
Just finished recording another incredible conversation with @OncBrothers #melanoma #immunotherapy Can't wait to share it with you all, stay tuned. https://t.co/XYN4az92Ey
#RiversideFM
riverside.fm
Create your own studio-quality content.
2
1
11
Bravo ! @MOASC_Office and @oncologytube .. lets roll
Dr. Omid Hamid, MD kicks of the @MOASC_Office @ANCO_News Immuno-Oncology Symposium in Marina Del Rey, CA 👉 https://t.co/5LmwdEIZd7 Post Conference Video Interviews Will Be Posted Here: https://t.co/shIIqUZrIT and https://t.co/VXdOPgHcsK
@OmidHamidMD @SirohiBhawna
6
2
16
During the last month I have ached for the with and wisdom of Jeffrey Weber MD. Don't forget the humor and biting truth that came on the side. On the one year anniversary of his passing we can only fight on in his memory and access the programming that he gave us ...
6
5
30
Nothing to see here (?!). Ousted @US_FDA Vaccine Chief Returns - how will this affect vaccine and @Replimune decisions ?
nytimes.com
Dr. Vinay Prasad’s rehiring was an unusual instance of a federal official targeted by the right-wing activist Laura Loomer being brought back into the Trump administration.
1
0
7
Famous "Weber Rules" Remembering Dr. Jeffrey Weber’s Impact on Colleagues and Patients @nyulangone @ASCO
https://t.co/QyifTpaXdd
9
13
67
The @FDA Said No — Now We Need Your Voice @MelanomaReAlli
@Replimune RP-1 #melanoma
https://t.co/kJs00NxxVg
aimatmelanoma.org
Dear Friends, A recent FDA decision denied approval of a promising new treatment called RP1 for advanced melanoma—one that showed encouraging results for patients who had failed first-line therapy....
1
2
16
LAG-3 blockade may help with #Parkinsonsdisease Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synuclein @NatureComms targets for therapeutic strategies aimed at preventing neurodegeneration in Parkinson’s disease and related α-synucleinopathies
link.springer.com
Nature Communications - Pathologic α-synuclein spreads from cell-to-cell through binding to the lymphocyteactivation gene 3 (Lag3). Here, the authors demonstrate that the amyloid β...
0
0
3
That feeling when 7+ years of work lands on the front page of @NEJM—and one of the people I respect most, @KoheiShitara , writes the editorial. Honored to share this moment with you, Kohei. Here’s to a decade of friendship, and curing gastric cancer. #Matterhorn @MSKCancerCenter
It’s my great honor to write the editorial for the pivotal MATTERHORN study @NEJM @YJanjigianMD @ASCO More global collaboration is needed to further improve outcomes for our patients with gastric/GEJ cancer.@OncoAlert @oncodaily
https://t.co/ZhCzZdCFq4
15
29
256
#melanoma & Cutaneous Malignancies 2/21/26 #LosAngeles FREE REG CODE: HAMID IN-PERSON https://t.co/VmzEH73QPx)
0
3
9
RP1 (vusolimogene oderparepvec) in PD1/CTLA failed #melanoma data with ongoing phase 3 trial and @FDA PDUFA 7-22 - safe, effective option for patients. soon for other solid tumors @JCO_ASCO @Replimune accruing @angelesclinic
https://t.co/KCZjhYCez5
0
6
16
#ScienceSaturday 🏃♂️🧬 Can exercise really help fight #cancer? 📢 A new study in @CellCellPress shows exercise rewires the gut #microbiome to enhance immune responses against tumors. ➡️ @CatMPhelps et al. found exercise increases levels of a microbiota-derived metabolite called
2
20
50
#melanoma & Cutaneous Malignancies 2/21/26 #LosAngeles FREE REG CODE: HAMID IN-PERSON https://t.co/VmzEH73QPx)
0
3
9
A point of clarification on the mayoral election. I don’t believe that money can buy elections. @KamalaHarris outspent @realDonaldTrump massively and lost in a veritable landslide. That said, being able to fund a campaign is table stakes for running for office. When I wrote
I awoke this morning gravely concerned about New York City. I thought “What has NYC become that an avowed socialist who has supported defunding the police, whose solution to lowering food prices is city-owned supermarkets, who doesn’t understand that freezing rents will only
617
477
5K
Thank you to @OncEd for the ability to discuss #ASCO25 @ASCO #melanoma abstracts of import https://t.co/pADs2MwUKf
0
1
5
Carnage continues @ASCO #ASCO25 meeting with pharmacist partners with most small bio delivering bad news of trial early termination or restriction/termintion of expansion cohorts. #earlydevelopment
1
1
5